Ligand-Functionalized Substrates for Virus Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current chromatographic methods for capturing and purifying viruses from biological samples face bottlenecks in throughput and efficiency due to limitations in diffusion and binding capacity, leading to high pressure drops and economic challenges with conventional polymeric resins.
Innovation Solution
Development of ligand-functionalized substrates with grafted electrophilic and ionic groups, derived from specific ligand compounds, which enhance binding selectivity for charged biomaterials like viruses, allowing for efficient capture and removal while excluding other proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional column chromatography techniques are used for virus capture and purification, then separation and purification can be achieved, but throughput is low and bottlenecking occurs in downstream purification
Solution Approach 1:
The patent transitions from conventional one-dimensional column chromatography to two-dimensional chromatography where the ligand-functionalized substrate provides an additional separation dimension. This enables parallel processing and significantly increases throughput by allowing simultaneous separation of multiple components rather than sequential processing through a single column.
Solution Approach 2:
The invention employs porous ligand-functionalized substrates that provide high surface area and enhanced mass transfer characteristics. The porous structure allows rapid diffusion of viruses and biomacromolecules throughout the substrate, eliminating the slow diffusion limitations of conventional resins and enabling high-throughput operation without bottlenecking.
2Productivity
If the diameter of the chromatography column is increased to alleviate throughput bottlenecks, then throughput may improve, but packing difficulties and channeling problems increase
Solution Approach 1:
The patent utilizes thin-film ligand-functionalized substrates that can be directly integrated into chromatography systems without requiring complex column packing procedures. These flexible thin films eliminate the mechanical handling and packing difficulties associated with large-diameter columns while maintaining high throughput capability through their large surface area and optimized flow characteristics.
3Reliability
If conventional polymeric resins are used for chromatographic separation, then separation based on various interactions can be achieved, but diffusion limitations and binding capacity constraints reduce efficiency
Solution Approach 1:
The invention creates composite ligand-functionalized substrates that combine the advantages of porous support structures with specifically engineered ligand layers. This composite architecture provides both the mechanical stability needed for reliable operation and the enhanced surface chemistry required for high-capacity, high-speed binding, overcoming the limitations of conventional homogeneous polymeric resins.
4Manufacturing precision
If absorption operation is shut down upon breakthrough detection in conventional chromatography, then product purity is maintained, but dynamic capacity is significantly less than static capacity
Solution Approach 1:
The patent enables continuous absorption operation by employing ligand-functionalized substrates with such high dynamic binding capacity that breakthrough can be maintained at controlled levels without compromising product purity. The enhanced capacity allows the system to operate continuously at or near maximum efficiency, fully utilizing the resin capability rather than shutting down early as in conventional chromatography.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ligand-functionalized substrates significantly improve the binding selectivity and capacity for viruses, enabling high-throughput purification with reduced pressure drops and increased economic viability by selectively capturing target biomaterials while passing non-specific materials.
Implementation Method 1
the functionalized substrates include a base substrate, preferably a porous base substrate, which has been modified to provide grafted ligand groups having the requisite specific binding capacity for binding charged biomaterials, such as viruses
Implementation Method 2
There is further need in the art for ligand functionalized membranes that overcome limitations in diffusion and binding
Data Source
AI summary
Ligand functionalized substrates, use of such functionalized substrates and a method for viral capture are disclosed.


